This article is more than 5 years old. Information may no longer be current.
Zimmer Biomet receives FDA 510(k) clearance for revision knee system
Click Here to Manage Email Alerts
Zimmer Biomet Holdings Inc. announced it received FDA 510(k) clearance for the Persona revision knee system, which is intended for revision knee replacement procedures.
According to a company press release, the revision knee system provides anatomic components designed to match a patient’s anatomy for a personalized fit. The revision knee system allows surgeons to address simple and complex revision procedures with the flexibility to use their preferred surgical approach.
“The clearance of the Persona revision knee system gives us the ability to provide surgeons with a full-service portfolio for the continuum of knee arthroplasty care, from diagnostic tools, cement spacer technologies to re-implantation solutions,” Todd Davis, Zimmer Biomet’s vice president and general manager of the global knee business, said in the release. “The Persona revision knee system gives surgeons the flexibility to truly tailor an implant solution based on each patient’s unique anatomy for a natural fit and function.”
Reference :